Screener
SG&A at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001906324-26-000033
| Line item | Three Months Ended / June 28, 2026 | Three Months Ended / June 29, 2025 | Six Months Ended / June 28, 2026 | Six Months Ended / June 29, 2025 |
|---|---|---|---|---|
| Total revenues | $630.9 | $613.9 | $1,250.7 | $1,306.7 |
| Cost of sales, excluding amortization of intangibles | 358.0 | 339.0 | 714.0 | 688.5 |
| Selling, marketing and administrative | 189.7 | 178.0 | 389.0 | 365.0 |
| Research and development | 48.7 | 45.7 | 93.6 | 98.9 |
| Amortization of intangible assets | 49.0 | 47.9 | 95.8 | 95.9 |
| Restructuring, integration and other charges | 6.5 | 178.9 | 10.9 | 195.0 |
| Other operating expenses | 0.8 | 5.1 | 1.0 | 11.5 |
| Operating loss | (21.8) | (180.7) | (53.6) | (148.1) |
Item 1. Financial Statements (unaudited)
FAQ
- What is QuidelOrtho Corporation's SG&A?
- QuidelOrtho Corporation (QDEL) reported SG&A of $189.7M in Q2 2026.
- How has QuidelOrtho Corporation's SG&A changed year-over-year?
- QuidelOrtho Corporation's SG&A increased by 6.6% year-over-year, from $178M to $189.7M.
- What is the long-term trend for QuidelOrtho Corporation's SG&A?
- Over 4 years (2021 to 2025), QuidelOrtho Corporation's SG&A has grown at a 32.8% compound annual growth rate (CAGR), from $239.6M to $746.3M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about QuidelOrtho Corporation's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude